Search Results

Saved Studies



 
Active, currently enrolling    Who can join   

Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US

Keywords: Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type: Prospective Cohort Study with Direct Patient Contact   |  Region: Georgia
Active, currently enrolling    Who can join   

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence

Keywords: Oncology (Adult);
Study Type: INTERVENTIONAL   |  Region: Hawaii
Enrollment complete    Who can join   

BO41843: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Keywords: Oncology (Adult);
Study Type: INTERVENTIONAL   |  Region: Hawaii
Active, not yet recruiting    Who can join   

A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Keywords: Hidradenitis Suppurativa; Hidradenitis; Acne inversa; HS; Povorcitinib;…
Study Type: INTERVENTIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease

Keywords: Oncology (Adult);Breast Cancer; ctDNA; Neoplasms by Site; Neoplasms; Breast…
Study Type: OBSERVATIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy

Keywords: Ovarian Neoplasms, Endocrine Gland Neoplasms, Neoplasms by Site, Neoplasms,…
Study Type: INTERVENTIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors With Blinatumomab in Patients With Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

Keywords: Burkitt Lymphoma, Epstein-Barr Virus Infections, Herpesviridae Infections, DNA…
Study Type: INTERVENTIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG

Keywords: Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by…
Study Type: INTERVENTIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer

Keywords: Breast Carcinoma In Situ, Carcinoma in Situ, Carcinoma, Neoplasms, Glandular and…
Study Type: INTERVENTIONAL   |  Region: California - Northern
Active, currently enrolling    Who can join   

National Liver Cancer Screening Trial

Keywords: Hepatocellular carcinoma surveillance; GALAD; Alpha Fetoprotein; Oncology…
Study Type: INTERVENTIONAL   |  Region: California - Northern
12345678910...